Alliances
The two companies are eying the second half of this year to begin clinical trials on their combined project and, if the vaccine meets expectations, the companies said it could be available for use in the second half of 2021.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 13, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 10, 2020.
Rexahn said it notified Merck on April 7 of its decision to discontinue the development of RX-5902 for the treatment of metastatic triple-negative breast cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 9, 2020.
AstraZeneca made an announcement describing its internal and partnering efforts to battle COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
“We are excited to partner with Roche’s strong research and development team,” said Michael Gilman, Arrakis’ chief executive officer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.
Gilead Sciences and Second Genome forged a four-year strategic collaboration that will boost chances to discover and develop new targets and drug candidates for the treatment of inflammatory bowel disease through microbiome research.
PRESS RELEASES